|
|
Other links at Articles > Business of Medicine |
| 1. |
Baxter Recalls All Remaining Heparin Vial Products
|
|
|
Baxter International is now recalling from the market all remaining lots and doses of its heparin sodium multidose and single-dose vials for injection and its heparin lock flush solutions. Medscape Medical News
|
| 2. |
Intensive-Glycemic-Control Arm of ACCORD Stopped
|
|
|
The blood-glucose-lowering part of the ACCORD trial in patients with type 2 diabetes at especially high risk of heart disease has been stopped prematurely because of a higher rate of mortality in the patients in the intensive arm vs that in the standard arm. Heartwire
|
| 4. |
Obesity Drug Prescriptions Soar in Britain
|
|
|
Doctors in England are writing over a million obesity drug prescriptions a year, eight times more than in 1999, health data showed on Thursday. Reuters Health Information
|
| 5. |
Bayer Stops Late-Stage Nexavar Trial
|
|
|
Bayer HealthCare, a U.S. based unit of Bayer AG, said it stopped a late-stage trial of Nexavar in patients with non-small cell lung cancer, after an independent data monitoring committee concluded that the study would not meet its main goal of improved overall survival. Reuters Health Information
|
|
|
